Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol for the Prevention of the Progression of Esophageal Varices in Hepatitis B Related Cirrhotic Patients
NCT03736265Unknown
- Sponsor
- Beijing Friendship Hospital
- Start
- Oct 2017
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of carvedilol in esophageal varices (2 arms), sponsored by Beijing Friendship Hospital. Primary endpoint: Progression Incidence of esophageal varices at 2 years. Status: unknown.
02
Drugs
carvedilol
03
Conditions
esophageal varices
Beyond the preview
Go deeper on NCT03736265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03736265.